D. Derudas, “Guest Editor: Pellegrino Musto HOW FIRST-LINE THERAPY IS CHANGING IN NON-TRANSPLANT ELIGIBLE MULTIPLE MYELOMA PATIENTS”., Mediterr J Hematol Infect Dis, vol. 17, no. 1, p. e2025025, Feb. 2025.